What are the treatments for prostate cancer? CRPC ifARPI fails
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Reviewed by Dr. Chris Apfel, MD/PhD (UCSF)
Prostate Cancer Treatments: When ARPI Therapy Doesn't Work
I appreciate your specific question about treatment options when androgen receptor pathway inhibitor (ARPI) therapy—medications that block hormone signals fueling prostate cancer—hasn't been effective.
Treatment Options After ARPI Failure
According to the NCCN Guidelines for Patients: Advanced-Stage Prostate Cancer (2024), when hormone-blocking treatments don't work, several evidence-based options are available for castration-resistant prostate cancer (CRPC):
1. Biomarker-Targeted Therapy (PARP Inhibitors)
These medications target specific genetic mutations in cancer cells:
- Rucaparib (Rubraca)
- Olaparib (Lynparza)
- Niraparib and abiraterone (Akeega)
- Talazoparib (Talzenna)
The NCCN notes that about 1 in 4 patients with metastatic hormone-resistant prostate cancer have genetic mutations (like BRCA1 or BRCA2) that these drugs can target. Your doctor will perform molecular tumor testing to see if your cancer has these mutations.
2. Radiopharmaceuticals (Targeted Radiation)
These are radioactive medicines injected into your bloodstream that find and kill cancer cells:
-
Lutetium-177 (Pluvicto): Targets a protein called PSMA on prostate cancer cells. Given as an IV infusion every 6 weeks for up to 6 doses. Requires a PSMA-PET scan first to confirm eligibility.
-
Radium-223 (Xofigo): Used when cancer has spread to bones but not other organs. Given as monthly injections for 6 months. Often combined with bone-protecting medications.
3. Radiation Therapy
External beam radiation therapy (EBRT) uses high-energy rays to target cancer cells precisely, particularly useful for regional disease or bone metastases.
Important Next Steps
Your oncologist should:
- Order genetic testing to determine if PARP inhibitors are appropriate
- Discuss which option best fits your specific cancer stage and location
- Review potential side effects with you
- Monitor your response with PSA levels and imaging
This is a personalized decision—what works best depends on your cancer's specific characteristics, where it has spread, and your overall health.
Would you like me to explain any of these treatments in more detail?
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with treatment for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ